RxDoctor Payments DataLook up a doctor →

Patricia Stephenson

Ophthalmology · Venice, FLNPI 1114988045

Payments from drug & device makers

$691,145in general payments, 2019–2025

Across 712 payments — averaging $970.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$150K
  • Oyster Point Pharma, Inc.$137K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$61K
  • Lensar, Inc.$56K
  • Dompe Farmaceutici S.p.a.$55K
  • Sun Pharmaceutical Industries Inc.$48K
  • plus $183K from 31 others
$39,172in research payments, 2019–2025

Across 5 payments — averaging $7834.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bausch Health US, LLC$25K
  • Bausch & Lomb Americas Inc.$14K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bausch & Lomb Americas Inc.178$150,119
Oyster Point Pharma, Inc.17$137,472
Bausch & Lomb, A Division Of Bausch Health US, LLC99$61,301
Lensar, Inc.23$56,164
Dompe Farmaceutici S.p.a.2$54,805
Sun Pharmaceutical Industries Inc.81$48,033
Ocular Therapeutix, Inc.43$41,142
Carl Zeiss Meditec, Inc.44$37,587
Rxsight Inc10$36,717
Alcon27$15,013
Omeros Corporation25$11,793
Kala Pharmaceuticals, Inc.28$10,927
Sight Sciences, Inc.21$4,608
Novartis6$4,524
Topcon Healthcare, Inc.3$3,562
Eyepoint US, Inc.9$3,326
Alcon Research LLC2$2,450
Eyevance Pharmaceuticals LLC10$2,301
Ivantis, Inc13$2,293
Optos, Inc.1$1,500
Johnson & Johnson Surgical Vision, Inc.7$1,495
AbbVie(2 entities)17$1,428
Carl Zeiss Meditec USA, Inc.17$1,187
Tarsus Pharmaceuticals, Inc.6$316
Nova Eye, Inc.2$296
Shire North American Group Inc3$141
Carl Zeiss Meditec Cataract Technology Inc.1$108
Thea Pharma Inc.2$103
Bausch Health US, LLC1$102
Glaukos Corporation3$67
Dompe US, Inc.2$66
Dutch Ophthalmic, USA1$61
Teva Pharmaceuticals USA, Inc.3$52
Carl Zeiss Meditec AG2$39
Rayner Intraocular Lenses Limited1$17
Harrow Eye, LLC1$16
Aerie Pharmaceuticals, Inc.1$14

How this compares

$691,145 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.

See all ophthalmology providers in Florida →

Medicare billing

Part B allowed, 2024
$603,492
Medicare patients
1,756
Services billed
5,488

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Venice

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →